Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome

Clinical Chemistry

Volumn 52, Issue 2, 2006, Pages 322-325

  Apple, Fred S ^a,b   Ler, Ranka ^a   Chung, Adrine Y ^a   Berger, Michael J ^a   Murakami, Mary Ann M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ASSAY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POINT OF CARE TESTING; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SURVIVAL RATE;

ACUTE DISEASE; BIOLOGICAL MARKERS; CORONARY DISEASE; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SYNDROME; TROPONIN I;

EID: 31844449600     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.060293     Document Type: Article

References (18)

1. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquele G, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000;140:917-27.
2. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L, FRISC II Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: FRISC II sub study. J Am Coll Cardiol 2001;38:979-86.
3. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of the imprecision at low range concentrations of the assays for cardiac troponin determination. Clin Chem 2004;50:327-32.
4. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6.
5. Jaffe AS, Ravkilde J, Roberts R, Naslund V, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
6. Alpert JS, Thygesen K, for the Cardiology Committee for the Redefinition of Myocardial Infarction. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;21:1502-13.
7. Wu AMB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999;45:1104-21.
8. Venge P, Lagerquist B, Diderholm E, Lindahl B, Wallentin L, on behalf of the FRISC II Study Group. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II Substudy). Am J Cardiol 2002;89:1035-41.
9. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AHB, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005;51:2198-200.
10. Hamm CW, Goldmarin BU, Heeschen C, Kregmann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of a rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
11. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vican R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST-elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405-12.
12. Heeschen C, Deu A, Langenbrink L, Goldmann BU, Hamm CW. Analytical and diagnostic performance of troponin assays in patients suspicious acute coronary syndromes. Clin Biochem 2000;33:359-68.
13. Apple FS, Murakami MM, Quist H, Pearce LA, Wieczorek S, Wu AHB. Prognostic value of the Ortho Vitros Troponin I assay in patients with symptoms of myocardial ischemia: risk stratification using ESC/ACC recommended cutoff values. Am J Clin Path 2003;120:114-20.
14. Newby LK, Storrow AB, Gibler WB, Garvey JL, Tucker JF, Kaplan AL, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 2001;103:1832-7.
15. Apple FS, Anderson FP, Collinson P, Jesse RL, Kontos MC, Levitt MA, et al. Clinical evaluation of the First Medical whole blood, point of cure testing device for detection of myocardial infarction. Clin Chem 2000;46:1604-9.
16. Apple FS, Murakami MM, Christenson RH, Campbell JL, Miller CJ, Hock KG, et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta 2004;345:123-7.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Braunwald E, Antman EM, Beasley JW. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). 2002. Available at http://www.acc.org/ clinical/guidelines/unstable/unstable.pdf (accessed September 5, 2005).